396 related articles for article (PubMed ID: 12781078)
41. Treatment outcome for patients with primary NSCLC and synchronous solitary metastasis.
Xu Q; Wang Y; Liu H; Meng S; Zhou S; Xu J; Schmid-Bindert G; Zhou C
Clin Transl Oncol; 2013 Oct; 15(10):802-9. PubMed ID: 23430537
[TBL] [Abstract][Full Text] [Related]
42. Multimodality management of non-small cell lung cancer patients with brain metastases.
Ricciardi S; de Marinis F
Curr Opin Oncol; 2010 Mar; 22(2):86-93. PubMed ID: 20009927
[TBL] [Abstract][Full Text] [Related]
43. A matched-pair analysis comparing whole-brain radiotherapy plus stereotactic radiosurgery versus surgery plus whole-brain radiotherapy and a boost to the metastatic site for one or two brain metastases.
Rades D; Kueter JD; Pluemer A; Veninga T; Schild SE
Int J Radiat Oncol Biol Phys; 2009 Mar; 73(4):1077-81. PubMed ID: 18707817
[TBL] [Abstract][Full Text] [Related]
44. Phase II clinical trial of whole-brain irradiation plus three-dimensional conformal boost with concurrent topotecan for brain metastases from lung cancer.
Ge XH; Lin Q; Ren XC; Liu YE; Chen XJ; Wang DY; Wang YQ; Cao B; Li ZG; Liu ML
Radiat Oncol; 2013 Oct; 8():238. PubMed ID: 24125485
[TBL] [Abstract][Full Text] [Related]
45. Treatment options for patients with brain metastases from EGFR/ALK-driven lung cancer.
Doherty MK; Korpanty GJ; Tomasini P; Alizadeh M; Jao K; Labbé C; Mascaux CM; Martin P; Kamel-Reid S; Tsao MS; Pintilie M; Liu G; Bradbury PA; Feld R; Leighl NB; Chung C; Shepherd FA
Radiother Oncol; 2017 May; 123(2):195-202. PubMed ID: 28363487
[TBL] [Abstract][Full Text] [Related]
46. Stage III non-small cell lung cancer and metachronous brain metastases.
Moazami N; Rice TW; Rybicki LA; Adelstein DJ; Murthy SC; DeCamp MM; Barnett GH; Chidel MA; Suh JH; Blackstone EH
J Thorac Cardiovasc Surg; 2002 Jul; 124(1):113-22. PubMed ID: 12091816
[TBL] [Abstract][Full Text] [Related]
47. Combined Immunotherapy and Stereotactic Radiotherapy Improves Neurologic Outcomes in Patients with Non-small-cell Lung Cancer Brain Metastases.
Enright TL; Witt JS; Burr AR; Yadav P; Leal T; Baschnagel AM
Clin Lung Cancer; 2021 Mar; 22(2):110-119. PubMed ID: 33281062
[TBL] [Abstract][Full Text] [Related]
48. Oligo-recurrence predicts favorable prognosis of brain-only oligometastases in patients with non-small cell lung cancer treated with stereotactic radiosurgery or stereotactic radiotherapy: a multi-institutional study of 61 subjects.
Niibe Y; Nishimura T; Inoue T; Karasawa K; Shioyama Y; Jingu K; Shirato H
BMC Cancer; 2016 Aug; 16(1):659. PubMed ID: 27542716
[TBL] [Abstract][Full Text] [Related]
49. Combined treatment of non-small cell lung cancer with synchronous brain metastases: a single center experience.
Melloni G; Bandiera A; Gregorc V; Carretta A; Ciriaco P; Viganò M; Franzin A; Bolognesi A; Picozzi P; Zannini P
J Cardiovasc Surg (Torino); 2011 Aug; 52(4):613-9. PubMed ID: 21792167
[TBL] [Abstract][Full Text] [Related]
50. Prolonged survival of patients with EGFR-mutated non-small cell lung cancer with solitary brain metastases treated with surgical resection of brain and lung lesions followed by EGFR TKIs.
Gui Q; Liu J; Li D; Xu C
World J Surg Oncol; 2017 Oct; 15(1):184. PubMed ID: 29037198
[TBL] [Abstract][Full Text] [Related]
51. A phase III trial of topotecan and whole brain radiation therapy for patients with CNS-metastases due to lung cancer.
Neuhaus T; Ko Y; Muller RP; Grabenbauer GG; Hedde JP; Schueller H; Kocher M; Stier S; Fietkau R
Br J Cancer; 2009 Jan; 100(2):291-7. PubMed ID: 19127261
[TBL] [Abstract][Full Text] [Related]
52. Emerging Trends in the Management of Brain Metastases from Non-small Cell Lung Cancer.
Churilla TM; Weiss SE
Curr Oncol Rep; 2018 May; 20(7):54. PubMed ID: 29736685
[TBL] [Abstract][Full Text] [Related]
53. [Whole Brain Irradiation and Hypo-fractionation Radiotherapy for the Metastases in Non-small Cell Lung Cancer].
Gu X; Zhao Y; Xu F
Zhongguo Fei Ai Za Zhi; 2016 Apr; 19(4):224-9. PubMed ID: 27118651
[TBL] [Abstract][Full Text] [Related]
54. [Sequential treatment of VmP regimen and whole brain radiotherapy for small cell lung cancer patients with brain metastases].
Yue X; Zang QC
Ai Zheng; 2004 Dec; 23(12):1671-6. PubMed ID: 15601558
[TBL] [Abstract][Full Text] [Related]
55. Combined treatment for non-small cell lung cancer and breast cancer patients with brain metastases with whole brain radiotherapy and temozolomide: a systematic review and meta-analysis.
Tian J; Luo Y; Xiang J; Tang J
J Neurooncol; 2017 Nov; 135(2):217-227. PubMed ID: 28726172
[TBL] [Abstract][Full Text] [Related]
56. Brain metastases: a medical neuro-oncology perspective.
Chamberlain MC
Expert Rev Neurother; 2010 Apr; 10(4):563-73. PubMed ID: 20367208
[TBL] [Abstract][Full Text] [Related]
57. Radiotherapy plus carboplatin and teniposide in patients with brain metastases from non small cell lung cancer.
Pronzato P; Bruna F; Neri E; Roveri D; Trabucchi A; Vanoli M; Vigani A; Vaira F; Losardo P; Bertelli G
Anticancer Res; 1995; 15(2):517-9. PubMed ID: 7539236
[TBL] [Abstract][Full Text] [Related]
58. [Mangement of brain metastases based on EBM].
Narita Y
Gan To Kagaku Ryoho; 2005 Apr; 32(4):463-7. PubMed ID: 15853211
[TBL] [Abstract][Full Text] [Related]
59. Brain metastases in non-small-cell lung cancer.
Dawe DE; Greenspoon JN; Ellis PM
Clin Lung Cancer; 2014 Jul; 15(4):249-57. PubMed ID: 24954227
[TBL] [Abstract][Full Text] [Related]
60. Outcome and prognostic factors in single brain metastases from small-cell lung cancer.
Bernhardt D; Adeberg S; Bozorgmehr F; Opfermann N; Hörner-Rieber J; König L; Kappes J; Thomas M; Unterberg A; Herth F; Heußel CP; Warth A; Debus J; Steins M; Rieken S
Strahlenther Onkol; 2018 Feb; 194(2):98-106. PubMed ID: 29085978
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
